NewLeaf Symbiotics is a development stage company based in the Bio-Research & Development Growth (BRDG) Park at the Danforth Plant Science Center in St. Louis, MO. Formerly known as TrophoMax LLC, NewLeaf is commercializing Pink Pigmented Facultative Methylotrophs (PPFMs) for broad applications to the agriculture and horticulture industries. PPFMs are microorganisms that supply several essential nutrients that all plants need to grow. When PPFMs are applied to plants in a prescribed manner, the plants have been shown to grow faster and stronger, and to generate higher yields. Utilizing symbiotic microorganisms such as PPFMs to enhance plant growth and health can reduce the need for synthetic chemicals and other treatments, resulting in more profitable and sustainable farming.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/10/13 | $7,000,000 | Series A |
Open Prairie Ventures Pangaea Ventures RockPort Capital | undisclosed |
| 07/10/17 | $24,000,000 | Series C |
Lewis & Clark Ventures Monsanto Growth Ventures  Open Prairie Ventures Pangaea Ventures RockPort Capital | undisclosed |
| 09/07/17 | $30,000,000 | Series C |
Lewis & Clark Ventures Monsanto Growth Ventures Open Prairie Ventures Pangaea Ventures RockPort Capital S2G Ventures The Yard Ventures | undisclosed |
| 12/19/23 | $45,000,000 | Series D |
Gullspang Re:Food Leaps by Bayer Otter Capital S2G Ventures | undisclosed |
